SEC Tracker
Get the app

Vivos Therapeutics VVOS

Vivos Therapeutics meets Nasdaq equity rule

Item 8.01 Other events

Form
8-K
Filed
Importance
Routine
  1. Received Nasdaq compliance confirmation on Oct 20, 2026
  2. Must maintain equity compliance in next report
  3. Forward-looking statements risk include non-compliance

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Vivos Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Positron POSC public float $22M, Jun 30, 2025
  2. United Health Products UEEC public float $25M, Jun 30, 2025
  3. Allurion Technologies ALUR public float $21M, Jun 30, 2025
  4. Neuroone Medical Technologies NMTC public float $26M, Mar 31, 2025, over 18 months old
  5. Precision Optics POCI public float $26M, Dec 31, 2025